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Abstract: The complex nature of folliculogenesis regulation accounts for its susceptibility to maternal
physiological fitness. In obese mothers, progressive expansion of adipose tissue culminates with
severe hyperestrogenism and hyperleptinemia with detrimental effects for ovarian performance.
Indeed, maternal obesity is associated with the establishment of ovarian leptin resistance. This
review summarizes current knowledge on potential effects of impaired leptin signaling throughout
folliculogenesis and oocyte developmental competence in mice and women.
Keywords: leptin; obesity; ovary; folliculogenesis; oocyte
1. Introduction
Obesity is a prevalent disease worldwide, usually associated with infertility. Studies
in obese infertile females show the occurrence of systemic hyperestrogenemia, hyperin-
sulinemia, and associated ovarian dysfunction through premature follicular atresia and
anovulation [1]. Indeed, the ovaries of obese mothers have been shown to accumulate
lipids, high levels of reactive oxygen species [2], and inflammatory mediators [3]. Further-
more, obesity has been shown to hamper not only oocyte maturation and quality [4] but
also embryo development [5], with reported long term effects and direct causality between
obesity in the mother and prevalence of cardiovascular disease or cancer in the offspring.
We have recently identified striking links between gain in maternal body weight and
global gene expression profile in cumulus cells [6], reiterating not only the importance of
maternal metabolic state for ovarian function but also the dynamics of temporal alterations
in the ovary throughout obesity progression [6]. In the same work, we demonstrated the
establishment of leptin resistance in the ovary of diet-induced obese (DIO; abbreviations
listed after the main text) mice after 16 weeks (wk) in comparison to 4 wk [6]. Hence,
increased levels of leptin signaling inhibitor suppressor of cytokine signaling (SOCS) 3 were
observed already after 4 wk DIO [6] with potential implications for ovarian pathogenesis
during early obesity.
In the present narrative review, we revisit, first, physiological aspects governing follicu-
logenesis in mice and women, discussing the major molecular pathways preconizing devel-
opmental changes in both germ line and somatic cells. Second, we consider how maternal
obesity and, particularly, local changes in leptin signaling can affect the regulation of such
transitions, debating potential outcomes for oocyte quality and early embryo development.
2. Obesity and Ovarian Function
The worldwide epidemic of obesity has reached unprecedented levels and infertility
is described as an associated comorbidity [1]. Indeed, obese women were linked to poor
reproductive outcomes, such as anovulation or decreased conception rate [7]. Literature
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has evidenced the link between peripheral insulin resistance and functional hyperandro-
genism and hyperestrogenism [8], the main causes of anovulation and reduced endometrial
receptivity [1]. Studies in mice have shown how obesity-associated hyperinsulinemia and
diabetes can lead to delayed oocyte maturation in preovulatory follicles and apoptosis in
granulosa cells (GC) [9]. Furthermore, ovaries of obese women were shown to present high
levels of androstenedione and testosterone [8], responsible for premature follicular atresia.
Therefore, the endocrine imbalance observed in obese mothers affects directly the follicular
pool, reducing the number of primordial follicles and compromising fertility [10].
In recent years, studies, particularly in mouse models for obesity, have clearly revealed
the main readouts in ovaries from obese mothers. Indeed, the accumulation of lipids in
oocyte and surrounding GC or cumulus cells (CC) was shown to culminate with lipotoxicity
and inflammation, GC apoptosis, endoplasmic reticulum (EnR) stress in cumulus–oocyte
complexes (COCs) [11], and oocyte mitochondrial dysfunction [12]. Furthermore, we
have also shown, through DIO protocols in mice, dramatic changes in the expression of
genes regulating cytoskeletal organization and the formation of transzonal projections
(TZPs), which play a key role mediating the crosstalk between somatic cells and oocyte
during follicular growth [6]. Thus, maternal obesity has been linked to changes in local
cytokine milieu and signaling mediators of follicle growth, maturation, steroidogenesis,
and ovulation [3]. Ultimately, the oocyte quality was shown to be equally impaired, with
delayed meiotic maturation, abnormal mitochondrial distribution, and oxidative stress [13].
Finally, Robker and collaborators reported altered follicular fluid levels of metabolites such
as C-reactive protein and androgen activity in women [14], which have been associated
with cellular stress and impaired oocyte nuclear maturation [4]. Undeniably, literature
comprehensively describes the main features in the ovaries of obese mothers, but fewer
studies have functionally addressed the mounting response leading to ovarian failure and
hampered oocyte quality. Noteworthy, describing temporally the progression of events
in the ovaries of obese mothers is fundamental to understanding the pathophysiology of
ovarian failure and helping us delineate adequate treatments regarding disease progression.
2.1. Leptin—A Common Denominator between Ovarian Function and Obesity
During obesity progression, the ever-growing adipose tissue secretes large amounts
of leptin, which causes systemic hormonal imbalance. Leptin is mainly known to regulate
appetite at the central level [15] besides modulating the release of gonadotropin releasing
hormone (GnRH) neuron activity and gonadotropins [16]. Nonetheless, leptin is also an
important modulator of ovarian function [17]. Leptin long and short receptor isoforms
were detected in most cell types in murine ovary, particularly in the oocyte [17]. Likewise,
both isoforms of the leptin receptor (ObR) were previously detected in human GC and
theca cells (TC) [18]; as well, leptin and leptin soluble receptor were detected in human
follicular fluid [18,19]. Thus, leptin signaling components’ heavy representation in the
ovary makes the organ particularly vulnerable to the systemic hyperleptinemia observed
in obese mothers [20].
When leptin signals through the long isoform of its membrane receptor, leptin receptor
b (ObRb), a canonical cascade activates Janus kinase (JAK)/signal transducer and activator
of transcription (STAT) signaling. Conversely, noncanonical signaling results in insulin
receptor substrate (IRS)/phosphatidylinositol 3 kinase (PI3K)/protein kinase B (Akt) and
mitogen-activated protein kinase (MAPK)/extracellular signal regulated kinase (ERK)
signaling pathways activation (Figure 1). After binding the dimerized ObRb, leptin initially
mediates the phosphorylation of JAK2 with further transfer of the phosphate group to
three tyrosines within the BOX2 of ObRb. As a result: (i) SH2-domain containing protein
tyrosine phosphatase (SHP-2) can be phosphorylated, subsequently binding to the adapter
Grb-2 and activating downstream ERK1/2; (ii) STAT5 can be phosphorylated; and/or
(iii) STAT3 can be phosphorylated (Figure 1). Intriguingly, leptin can noncanonically
regulate components of the insulin signaling cascade. After ObRb activation, IRSs can
be phosphorylated by JAK2 with subsequent activation of PI3K pathway. As a result,
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phosphatidylinositol-3,4,5-triphosphate (PIP3) is generated with further activation of PIP3-
dependent serine/threonine kinases, such as phosphoinositide-dependent kinase (PDK)
1,2, a conserved activator of Akt, which in turn regulates downstream signaling [21]. With
regard to the ERK signaling, leptin can activate the MAPK pathway mainly through two
different ways: (i) first, after phosphorylation of ObRb tyrosine 985 by JAK2, SHP-2 is
recruited and binds Grb-2, resulting in ERK activation [22]; or (ii) second, the short isoform
of ObR, which possesses only BOX1 in the receptor domain and lacks tyrosine sites, can also
activate SHP-2 and Grb-2 complex through JAK2 (Figure 1), followed by mitogen-activated
protein kinase kinase (MEK) 1 and downstream phosphorylation of ERK1/2 [23]. It is
noteworthy that, despite its effects on ERK activation, leptin can also interact with protein
kinase C (PKC) and further activate ERK, playing both stimulatory and inhibitory effects
on PKC.
Figure 1. Schematic representation of leptin signaling pathway cascade. Leptin binds to its dimerized
membrane receptor, and signal propagation starts. Janus kinase 2 (JAK2) phosphorylation causes
transition of phosphate groups to three tyrosines within BOX2 of ObR and activation of (i) SH2-
domain containing protein tyrosine phosphatase (SHP-2), which, in turns, binds its adapter molecule
Grb-2 and activates downstream signaling, resulting in extracellular signal regulated kinase (ERK)
1/2 activation, (ii) signal transducer and activator of transcription (STAT) 5 activation and (iii) STAT3
activation. The phosphorylation of JAK2 also activates the MAPK signaling pathway and promotes
SH2B adaptor protein 1 (SH2B1) and insulin receptor substrate (IRS) binding, which initiates the
phosphatidylinositol 3 kinase (PI3K) pathway, which leads to phosphorylation of protein kinase B
(Akt), mammalian target of rapamycin (mTOR) and forkhead box O1 (FOXO1) activation. During
hyperactivation of the leptin signaling pathway, two main inhibitors can be transcribed—protein
tyrosine phosphatase (PTP) 1B, which dephosphorylates JAK2 and suppressor of cytokine signaling
(SOCS) 3, which blocks tyrosine and JAK2 phosphorylation. Created with BioRender.com, accessed
on 1 November 2020.
Concerning the role of leptin in the ovary, evidence gathered from studies with leptin
or ObR deficient mice, as well as women, confirmed their infertility and altered pubertal
development [24,25]. Functionally, leptin actions in the ovary were shown to have a
bimodal nature. In vivo and in vitro studies in mouse ovarian explants [26] evidenced the
dose-dependent effect of leptin on progesterone (P4) synthesis, with low doses stimulating
and high doses inhibiting expression of enzymes involved in P4 synthesis [26]. Also,
studies in other species corroborated the aforementioned observations as the in vitro
treatment of equine luteal cells with lower doses of leptin supported P4 secretion, whereas
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higher doses presented no effect [27]. Particularly regarding follicular dynamics, studies
in mice showed that high levels of circulating leptin blocked folliculogenesis, but lower
circulating levels of leptin supported the transition from primary to secondary follicle [28].
Conversely, the in vitro treatment of mouse follicles with mouse recombinant leptin once
more revealed a dose-dependent response with higher treatment doses inhibiting follicular
growth [29]. Presently, we used the data from Zhang and co-workers’ recent report profiling
the transcriptome of GC and oocytes isolated from different stages of folliculogenesis in
women [30] and plotted the main components of the leptin signaling pathway in order
to understand if their expression profile could be linked to a leptin concerted role during
particular developmental stages. Indeed, we confirmed some leptin signaling components,
such as protein tyrosine phosphatase non-receptor type 2 (PTPN2), protein tyrosine phosphatase
(PTP) 1B, or STAT3, were abundantly transcribed in both oocytes and GCs throughout
folliculogenesis, whereas others, such as SOCS3, presented very low expression in both
cell types under physiological conditions, particularly in later stages of folliculogenesis
(Figure 2). Finally, we have recently shown that obesity progression in DIO mice alters
leptin signaling in the ovary with increased leptin signaling in the ovary of 4 wk DIO
mice, being followed by the establishment of leptin resistance in the ovaries of 16 wk
DIO mice [6]. Indeed, expression levels of SOCS3 in ovarian extracts were dramatically
increased already at 4 wk DIO [6]. Therefore, our findings, as well as the observations
on leptin signaling component expression in oocytes and GCs from women’s follicles,
clearly suggest that the impairment of leptin signaling in the ovaries of obese mothers may
contribute to pathogenesis of ovarian failure, particularly given leptin’s established role in
ovarian function.
Figure 2. Heatmap representing the expression level of transcripts from the leptin signal-
ing pathway components in human oocyte and granulosa cells (GC) throughout folliculogene-
sis. Primordial = primordial follicle; Primary = primary follicle; Secondary = secondary follicle;
Antral = antral follicle; Preovulatory = preovulatory follicle. Color code from blue to red indicates
the relative gene expression level from low to high, respectively. Data from Zhang et al. 2018 [30]. Lep-
tin receptor (LEPR), suppressor of cytokine signaling 3 (SOCS3), SH2B Adaptor Protein 1 (SH2B1),
Janus kinase 2 (JAK2), signal transducer and activator of transcription (STAT), protein tyrosine
phosphatase non-receptor type 2 (PTPN2), protein tyrosine phosphatase (PTP) 1B.
2.2. Other Adipokines and Ovarian Function during Obesity
Obesity and progressive expansion of white adipose tissue are largely associated
with dramatic changes in the adipokine secretory profile, which ultimately lead to the
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establishment of a proinflammatory, atherogenic, and diabetogenic systemic environment.
Indeed, during obesity, the adipose tissue secretes adipokines other than leptin with
potential consequences for ovarian function regulation. Making a full characterization of
all adipokines and their potential involvement in ovarian function regulation is certainly
beyond the scope of the present review. Nonetheless, literature highlights both local
and central regulatory roles of major adipokines, such as adiponectin, visfatin, omentin,
and resistin in folliculogenesis [31]. Therefore, in the present section, we briefly discuss
potential outcomes for folliculogenesis associated with changes in the secretory profile of
main adipokines other than leptin during obesity.
Adiponectin is known as the most abundant circulating adipokine in humans, and its
receptors, adiponectin receptor 1 and 2, were shown to be ubiquitously expressed in female
reproductive tissues, including the ovaries [32]. Adiponectin’s main systemic roles encom-
pass the increase in insulin sensitivity in both liver and muscle, suppression of hepatic
gluconeogenesis, and promotion of fatty acid β-oxidation in the skeletal muscle [33]. Fur-
thermore, adiponectin is also known to have a ‘beneficial’ role in reproduction [31]. Indeed,
under physiological levels, a number of adipokines, such as visfatin, omentin and vaspin,
or leptin itself, have been described as ‘beneficial’ for reproduction and ovarian func-
tion [31]. In this regard, leptin’s prominent role in ovarian function was mainly evidenced
by reports on anorectic or undernourished women [34], corroborating the importance of
leptin’s exact physiological amounts for ovarian homeostasis [34]. At physiological levels,
adiponectin was shown to modulate steroidogenesis and promote oocyte maturation [35],
as well as participating in ovulation and supporting early embryo development in various
species [35,36]. Interestingly, a recent study has revealed adiponectin’s role in preventing
the hyperactivation of primordial follicles in mice treated with a high protein diet [37].
Therefore, decreased circulating levels of adiponectin observed in obese mothers might
negatively contribute to ovarian function regulation.
Another particular adipokine, resistin, was shown not only to be increased in circula-
tion during obesity, but also to synergize with leptin on SOCS3 upregulation in various
tissues [38]. Centrally, resistin was shown to lower hypothalamic ObRb transcript levels,
contributing to central leptin resistance [38]. Indeed, resistin’s role modulating the secretion
of reproductive hormones at the pituitary level was previously evidenced in sheep [39]. As
revisited elsewhere, resistin was shown to be widely expressed in the ovaries, particularly
in rodent, bovine, porcine, and human TC, GC, and oocytes, modulating steroidogenesis
and supporting androgen production [40]. Hence, resistin appears to be another major
adipokine capable of modulating ovarian function in obese mothers. Therefore, the mul-
tiple contribution of different adipokines to ovarian failure during obesity shall not be
neglected. Indeed, the difficulties of studying obesity and its comorbidities rely on its
polygenic nature, very often largely simplified by the use of monogenic disease models.
3. Revisiting Folliculogenesis in Mice and Women: A Morphofunctional
Characterization
The complex nature of folliculogenesis regulation certainly accounts for the vulnera-
bility the ovaries present to the hormonal imbalance seen in obese mothers [7]. Generally,
obesity may affect the oocyte and somatic cells at each single developmental stage of
folliculogenesis (Figure 3) with the incidence of obesity earlier in life posing a greater threat
for the quality of the gamete later in adulthood [41]. Hence, in this section, we revisit
folliculogenesis, analyzing major cellular events taking place throughout the long journey
the female gamete makes from primordial follicle until fertilization, based on lessons learnt
from studies in mice and in humans (Table S1 summarizes the nature of the study presented
in the text).
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Figure 3. Diagram of folliculogenesis in mice and women. Approximately five weeks (wk) post coitum (pc) in women and
10.5 days (d) pc in mice, primordial germ cells (PGC) arrive at the genital ridge. Germline cysts start breaking 15 wk later in
women and 7 days later in mice, creating the primordial follicles. During the peripartum period in woman, and within
3 days after birth in mice, primordial follicles are created. The process of follicle development in women is asynchronous,
with menstrual cyclicity being started at puberty. In mice, the first wave of follicle development is detected around postnatal
day 7, when the first primary follicles are originated, followed by secondary follicles detected at postnatal day 12 and early
antral follicles around postnatal day 21. When mice reach sexual maturity, cyclic recruitment of follicles begins. After
ovulation metaphase II (MII) oocyte is released into the oviduct where fertilization takes place, followed by early embryo
development. Created with BioRender.com, accessed on 1 November 2020.
3.1. Primordial Follicle Assembly
In the mouse, primordial germ cells (PGC) arrive at the genital ridge on 10.5 days post
coitum (dpc) and divide by mitosis with incomplete cytokinesis for the subsequent 3 days,
originating the germline cysts (Figure 3) [42]. Next, oogonias enclosed in germline cysts en-
ter the meiosis prophase and are named as oocytes. This is the beginning of a journey with
two distinctive ends, the success of ovulation and eventual fertilization or the inevitable
condemnation of follicular atresia. Oocyte progresses to the diplotene stage of prophase I
of meiosis, remains arrested at this stage from 17.5 dpc, and resumes meiosis only after
the surge of luteinizing hormone (LH) just before ovulation (Figure 3) [43]. Prior to cyst
breakdown, mitochondria divide and reorganize in the cysts, suggesting a process of active
mitochondrial selection [44]. Germline cyst breakdown starts at 17.5 dpc in the mouse [45],
and follicles begin to form. The process of primordial follicle assembly is independent from
gonadotropin action, being mainly regulated locally by factors like neurotrophin (NT) 4,
brain-derived nerve factor (BDNF), folliculogenesis-specific basic helix–loop–helix (FIG-α).
Within three days after birth, the cortex of the ovaries is replenished with primordial folli-
cles, consisting of small oocytes surrounded by flattened GC, which remain dormant until
awakened by local factors (Figure 3) [44]. In humans, follicular development starts during
fetal life, and PGC first reach the gonadal ridge around the fifth wk of pregnancy [46].
They then divide mitotically until the fifth month of pregnancy, when PGC undergo the
first meiotic division and become arrested in prophase I. At this stage, germ cells are
surrounded by somatic cells, forming the primordial follicles (Figure 3) [46]. In primates,
the first wave of primordial follicle activation starts during fetal development, and multiple
preantral follicles can be found in the ovary at the sixth month of pregnancy in women,
with antral follicles often developing during the next two months [47]. As a result, the
ovary of a newborn is replenished with large antral follicles, which will invariably undergo
atresia [47].
3.2. Primary Follicle Development and Growth
The process of early folliculogenesis encompasses important structural and molecular
changes, with GC becoming cuboidal and the oocyte accumulating ribonuclease acid (RNA)
and protein. Moreover, stromal/mesenchymal cells associated with the primordial follicle
are presumably early stage precursors of TC in the primary follicle [48]. At last, primary
Int. J. Mol. Sci. 2021, 22, 4270 7 of 26
follicles are enclosed in basal lamina with one layer of GC (Figure 3). In secondary follicles,
fibroblast-like cells from ovarian stroma form the TC layer that surrounds the follicle
and, together with GC-derived aromatase, mediates the synthesis of steroid hormones
essential for oocyte growth. Follicles then develop a fluid-filled antrum, being designated
as antral follicles (Figure 3). Prior to ovulation, the surge of gonadotropins determines the
resumption of oocyte meiosis, which progresses from prophase I to metaphase II (MII).
Indeed, meiotic division is finished exclusively after fertilization [49]. In women, primor-
dial follicles are formed during the peripartum period with around one to two million
follicles being present at birth. These follicles form the follicular reserve, which determines
reproductive potential throughout their lifespan. In women, it takes approximately one
year for a primordial follicle to mature and reach the ovulation stage. The transition from
resting pool into growing follicle is highly dependent on the game of forces between
growth/differentiation and pro-apoptotic factors [46].
3.3. The Road to Ovulation
As in rodents, the progression from preantral to antral follicles in women deter-
mines the transition from gonadotropin-independent to gonadotropin-dependent follicular
growth, with further selection of the dominant follicle prior to ovulation. At puberty,
centrally released gonadotropins follicle-stimulating hormone (FSH) and LH promote
the development of antral follicles and the onset of ovulation, with only one single folli-
cle reaching the preovulatory stage during a menstrual cycle in humans (Figure 3) [46].
Conversely, in cycling mice, few follicles reach the preovulatory stage [50]. In women,
approximately seven million oocytes initially start developing in the ovaries, with only two
million oocytes present at birth [44] and approximately four hundred ovulating through-
out reproductive lifespan [51]. Conversely, the mouse ovaries present great variation in
oocyte number between strains, as well as rates of follicle loss [52], with approximately
seven thousand oocytes being present in the ovaries at 3 days after birth [53]. Follicular
response to the gonadotropin surge results in the rupture of the follicle wall. The dramatic
expansion of the follicle volume is mainly associated with increased ovarian blood flow
and enhanced capillary permeability, mediated by the activity of local proteolytic enzymes,
steroids, and arachidonic acid metabolites [54]. After ovulation, COCs are released into the
oviduct where, in the presence of sperm, fertilization takes place. Immediately after fertil-
ization, meiosis is completed, followed by the zygotic first mitotic division and activation
of transcription as the embryo develops until the blastocyst stage (Figure 3), the time of
implantation in both mice and humans [55].
4. Molecular Mechanisms Regulating Primordial to Primary Follicle Transition
The rate of primordial follicle assembly and transition to primary follicle sets both the
size and depletion rate of the primordial follicle pool. Therefore, its inadequate regulation
culminates with premature follicle loss and sterility. The formation of the follicular pool
and the first wave of primordial follicle activation is a synchronous process in rodents
and takes place between days 3 and 7 postnatal (Figure 3). Nonetheless, due to the lack
of gonadotropin activity, these follicles inevitably undergo atresia [56]. In primates, the
process is asynchronous with some primordial follicles leaving the resting pool before
others start meiosis [56], whereas remaining germ cells, mainly located peripherally, still
undergo mitosis [53]. Asynchronous follicle activation in domestic animals and humans
is notoriously difficult to study, hence, most of the studies on molecular regulation of
primordial follicle activation were undertaken in rodents. In the present section, we discuss
the molecular mechanisms controlling primordial to primary follicle transition, and how
obesity and altered leptin signaling can jeopardize its regulation.
4.1. The PI3K Pathway and Primordial to Primary Follicle Transition
Mouse studies with three particular phenotypes of transgenic animals unraveled the
main molecular pathways involved in primordial follicle activation. The first phenotype
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consisted of mice with premature follicle activation, follicle loss, and sterility. The second
phenotype presented follicles arrested in the primordial follicle stage, and in the third
phenotype, follicles did not progress beyond the primary follicle stage. Studies on afore-
mentioned models identified the PI3K pathway in the oocyte, together with the mammalian
target of rapamycin (mTOR) pathway in pre-GC, as major regulators of primordial follicle
activation (Figure 4). Indeed, ERK1/2 may regulate mTOR Complex (mTORC) 1 in pre-GC
with subsequent activation of cyclic adenosine monophosphate (cAMP)-response element
binding protein (CREB), which is known to promote the transcription of stem cell factor
(SCF), a main activator of PI3K signaling in the oocyte [57]. Also, studies with CREB
conditional knockdown in the ovary showed its regulatory role on pre-GC proliferation
and oocyte apoptosis [57]. After PI3K activation in the oocyte, phosphatidylinositol-4,5-
biphosphate (PIP2) is phosphorylated into PIP3, followed by Akt phosphorylation by
PDK1. In fact, Akt may further interact with forkhead box O3 (FOXO3) or ribosomal
protein S6 kinase beta-1 (S6K1) (Figure 4). Upon phosphorylation, pFOXO3 translocates
from the nucleus to the cytoplasm, thereby losing transcriptional activity. Indeed, FOXO3
works as a molecular switch, ensuring, together with cyclin-dependent kinase inhibitor
1B (p27), follicle dormancy, and blocking follicular recruitment and oocyte growth [58].
Alternatively, Akt may also phosphorylate and inhibit tuberous sclerosis complex (TSC) 2,
allowing for the activation of mTORC1 and S6K1/ribosomal protein S6 (rpS6), a pathway
mainly responsible for protein translation and ribosome synthesis (Figure 4) [59]. Thus,
Akt plays a key role in the primordial follicle fate, mediating survival during dormancy, as
well as follicle activation or atresia [59].
Studies in bovines and baboons have linked PDK1 deficiency, and subsequent down-
regulation of rpS6 in oocytes, to premature ovarian failure (POF) and loss of primordial
follicles [59]. On the other hand, deficiency of phosphatase and tensin homolog (PTEN), a
PI3K inhibitor, was seemingly associated with the overexpression of rpS6 and POF due to
hyperactivation of primordial follicles and consequent follicular atresia [59]. Mutations
in PTEN suggested its importance for maintenance of the primordial follicle pool [60].
Indeed, PTEN, together with regulators TSC1 and TSC2, negative regulators of mTOR
signaling, maintain the quiescence of primordial follicles [61]. Furthermore, in vitro treat-
ment of human ovarian cortical tissue with PTEN inhibitor resulted in primordial follicle
development to preovulatory stage [62]. Finally, studies with porcine neonatal ovaries
also showed the localization of PTEN, Akt, and FOXO3 in oocytes and GC of primordial,
primary, and secondary follicles, suggesting their role in primordial follicle activation
across species [63]. Literature describes additional factors involved in PI3K regulation and
primordial follicle activation, particularly, growth differentiation factor (GDF) 9 [64] or SCF
receptor (Kit). Mutations of the aforementioned factors resulted in folliculogenesis arrest
at the primary follicle stage [65]. Finally, the involvement of insulin was also reported
in primordial to primary follicle transition and its ability to inhibit FOXO3 through Akt
signaling [66]. Taken together, PI3K and mTOR signaling pathways appear to be master
regulators of primordial follicle activation. Precise control of these pathways is essential
for maintenance of the female reproductive lifespan and the preservation of primordial
follicles in quiescence.
Although the molecular mechanisms driving primordial to primary follicle transition
in women remain much less clear than in the mouse, a recent study by Zhang et al. identi-
fied a number of genes differentially expressed at this stage [30]. As previously discussed
in Section 2.1, the leptin signaling inhibitor SOCS3 presented its highest expression level
in GC from primordial follicles (Figure 2). Furthermore, functional pathways associated
with differently expressed genes (DEGs) during primordial to primary transition included
insulin signaling, GnRH, NT, and mTOR–PI3K, JAK–STAT pathways in both oocytes and
GC [30]. Thus, components of leptin signaling appear to be amid the physiological factors
regulating primordial to primary follicle transition in humans.
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Figure 4. Schematic representation of mammalian target of rapamycin (mTOR) and phosphatidyli-
nositol 3 kinase (PI3K) signaling pathway and its downstream regulators in the granulosa cells
(GC) and oocyte. Extracellular signal-regulated protein kinase 12 (ERK1/2) activates mTOR complex
1 (mTORC1) in pre-GC to initiate the activation of primordial follicles. mTORC1 activates cyclic
AMP-response element binding protein (CREB), which promotes stem cell factor (SCF) transcription
and stimulates PI3K signaling but also affects pre-GC proliferation and oocyte apoptosis. mTOR
signaling negative regulators TSC1 and TSC2 suppress mTORC1 activity. PI3K signaling pathway is
activated by SCF in the oocyte. PI3K phosphorylates phosphatidylinositol-4,5-biphosphate (PIP2) to
phosphatidylinositol-3,4,5-triphosphate (PIP3), which interacts with 3-phosphoinositide dependent
protein kinase 1 (PDK1) for subsequent phosphorylation of protein kinase B (Akt) and forkhead
box O3 (FOXO3) with its downstream mediator, cyclin-dependent kinase inhibitor 1B (p27). Upon
phosphorylation, the inhibitory effect of FOXO3 and p27 on cell cycle progression and oocyte growth
is inhibited, and the primordial follicle is recruited. Akt also activates ribosomal protein S6 kinase
beta-1 (S6K1) through inhibition of TSC2 with subsequent mTORC1 activation and further ribosomal
protein S6 (rpS6) phosphorylation, which leads to protein translation and ribosome synthesis. Factors
indicated in red are associated with follicle dormancy; molecules indicated in green are associated
with follicle activation. Created with BioRender.com, accessed on 1 November 2020.
In conclusion, studies in transgenic mice with oocyte and GC specific mutations
helped us identify the major roles of PI3K and mTOR signaling mediating primordial
follicle activation. More recently, a study in humans has revealed the involvement of
JAK–STAT signaling and SOCS3 in early folliculogenesis, highlighting the importance of
the leptin signaling pathway in primordial to primary follicle transition.
4.2. Obesity, Leptin Signaling and Primordial Follicle Activation
Studies in rodents have highlighted the effects of maternal obesity on ovarian failure
and, particularly, on PI3K dysregulation. A report in rats showed that DIO treatment led
to POF through activation of mTOR and suppression of sirtuin (SIRT) 1 signaling [67],
whereas the ovaries of mice fed a high-fat diet (HFD) presented aberrant expression levels
of PI3K pathway components [68]. Indeed, the putative crosstalk between leptin and the
PI3K pathway can be anticipated, mainly, through components of the insulin signaling
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cascade (Figure 1). After ObRb activation, JAK2 can phosphorylate IRs, with subsequent ac-
tivation of PI3K pathway [21]. This generates PIP3, which further activates PIP3-dependent
serine/threonine kinases, such as PDK1,2, responsible for activation of Akt, as previously
discussed (Figure 1) [21]. Indeed, a study in mice with a triple mutation in ObR tyrosines
linked follicle loss to the activation of PTEN/PI3K/Akt/mTOR signaling [69]. Further-
more, Panwar and colleagues showed the direct effects of leptin on the follicular pool
once passive immunization of prepubertal mice against leptin prompted the transition
of primordial to primary follicles [28]. Therefore, adequate levels of leptin signaling in
the ovary seem to prevent primordial follicle hyperactivation and help to maintain the
follicular pool. Concordantly, these observations suggest the decrease in leptin signaling
we have reported in the ovaries of 16 wk DIO mice [6] might accelerate the activation and
depletion of the primordial follicle pool.
We have previously linked SOCS3 overexpression in ovarian extracts of 16 wk DIO
mice with the establishment of leptin resistance [6]. Despite no previous characterization of
SOCS3’s putative role on follicular pool activation, its ability to inhibit the phosphorylation
of JAK2 and ERK is well established. As a result, SCF signaling could be disturbed in GC
(Figure 4), as well as PI3K activation in the oocyte, during primordial to primary follicle
transition in obese mothers. After reanalyzing Zhang’s data, we plotted the expression
level of leptin signaling components across all stages of folliculogenesis (Figure 2). Indeed,
we confirmed SOCS3 mRNA levels remained very low in both oocyte and GC throughout
folliculogenesis in women with regard to other components of the pathway (Figure 2).
Therefore, our previous results showing a dramatic increase in SOCS3 protein and mRNA
levels in the ovaries of 16 wk DIO mice invite the speculation of PI3K putative dysregulation
in primordial oocytes. Finally, the high mRNA level of PTPN2 observed in the oocyte
throughout folliculogenesis was also of particular relevance [30]. In fact, PTPN2 has
also been associated with the establishment of leptin resistance at central level [70] and,
therefore, appears to be an important candidate in the pathophysiology of ovarian failure
in obese mothers.
To conclude, previous associations between maternal obesity and decreased follicular
count can be linked to changes in local leptin signaling. Effects of leptin resistance can be
measured not only by lack of leptin action maintaining the follicular pool but also through
excessive levels of SOCS3, potential dysregulation of PI3K signaling, and accelerated
primordial follicle activation.
5. Molecular Regulation of Early Antral to Preovulatory Follicle Transition
The regulation of primary to secondary follicle transition is a process mostly paracrinally
regulated that relies mainly on the communication between GC and oocyte. Morphologi-
cally, GC proliferate from a single monolayer to multiple layers with rapid expansion of
the oocyte. Molecularly, the process is coordinated by local factors such as GC-derived
anti-Mullerian hormone (AMH) [71], which was shown to regulate oocyte-derived GDF9
activity in follicular growth [64]. In addition, the factors Kit and SCF [65], as well as LIM
homeobox protein (Lhx) 8, were shown to be involved in primary to secondary follicle
transition [72]. Finally, NOTCH [73] and mTOR signaling were reported to control GC
proliferation in primary follicle growth [74]. Conversely, after antrum formation, the
follicles then become responsive to gonadotropins, responsible for orchestrating major
events leading to preovulatory follicle formation, such as steroidogenesis, intercellular
communication, GC differentiation, and oocyte expansion. In this chapter, we discuss the
main pathways regulating preovulatory follicle formation, the particular involvement of
leptin signaling, and the disruptive effects of obesity and impaired leptin signaling.
5.1. Preovulatory Follicle Formation—The Role of Estradiol
The systemic increase in pituitary-released FSH was shown to promote growth of
early antral follicles as they became responsive to gonadotropins. In the mouse, after
intensive GC proliferation and follicle growth, several follicles became dominant while
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others underwent atresia. Follicular atresia is a highly regulated process of programmed
cell death, or apoptosis, particularly through local levels of FSH- mediated estradiol (E2)
and androgen activity [51]. Atresia is generally initiated in GC, which at first undergo
apoptosis through the activity of factors such as tumor necrosis factor (TNF) α or Fas
ligand [51]. Furthermore, androgens were identified to play a prominent role in atresia,
increasing the number of pyknotic GC and degenerated oocytes [75]. Novel mediators
of atresia have been recently characterized as micro RNA (miR) 26b [76] or miR146b [77],
shown to promote GC apoptosis in atretic follicles in pig ovaries [78]. Conversely, in
dominant follicles, FSH activity was shown to elevate E2 levels through GC aromatase
cytochrome P450 (CYP) 19A1 [50] with the upregulation of pro-survival growth factors:
insulin-like growth factor (IGF) 1, epidermal growth factor (EGF), and basic fibroblast
growth factor (FGF) [79]. Indeed, lack of FSH activity and low levels of E2 were associated
with increased androgen activity, apoptosis, and atresia [80].
Estradiol is a predominant circulating estrogen in humans [81]. Its synthetic pathway
starts in TC through the activation of the LH receptor and production of androgens from
cholesterol [82]. After being transferred to GC, androgens are further converted into E2
by aromatase CYP19A1, a step regulated by FSH receptor activity [82]. As previously
stated, the newly synthesized E2 plays a major role in dominant follicle selection [83]. Two
nuclear E2 receptors (ER) have been characterized as auto-, paracrine mediators of E2
local actions, the ERα and the ERβ. Interestingly, the expression of ERs was shown to be
controlled by gonadotropins [84], with ERβ being mainly evidenced in GC and ERα de-
tected in TC and interstitial cells [85]. Studies with double knockout mice for ERα and ERβ
showed the arrest of folliculogenesis at the secondary follicle stage [86]. Generally, after
activation of its nuclear receptors, E2 binds to specific regions of the DNA, the estrogens
response elements (EREs) [81], further regulating the transcription of genes controlling
oocyte maturation and growth [84]. More recently, ERβ was shown to mediate the ex-
pression of Junction Adhesion Molecule Like (Jaml), a gene needed for the communication
between GC and oocyte, as well as other genes Polypeptide N-Acetylgalactosaminyltransferase
(Galnt) 6 or Egf receptor (Egfr), necessary for preovulatory follicle development [87]. It is
noteworthy that detailed E2 genomic actions in antral follicle development have been
described elsewhere [88]. Nonetheless, E2 is also known to exert non-genomic actions
through the membrane receptor, the G protein-coupled estrogen receptor (GPER) 1 [81]. E2
non-genomic effects were shown to involve the activation of intracellular signaling path-
ways, such as the Phospholipase C (PLC)/PKC pathway, the Ras/Raf/MAPK pathway, the
PI3K/Akt kinase cascade, and the cAMP/protein kinase A (PKA) signaling pathway [81],
which culminate with the activation of transcription factors from the STAT family, nuclear
factor kappa B (NFκB), and CREB. Thus, E2 plays a prominent role in preovulatory follicle
formation, activating multiple pathways and mediating growth and expansion of both
somatic cells and oocyte.
Connexins are a family of proteins responsible for the organization of intercellular
membrane channels of gap junctions, which allow for the transport of molecules, ions, and
metabolites between GC and the oocyte. They were shown to be particularly important
for preovulatory follicle formation. Indeed, the ovaries of connexin (Cx) 37 knockout mice
showed follicular arrest at the preantral stage due to lack of bidirectional communication
between GC and oocyte [89]. Another Cx, the Cx43, was also shown to be highly expressed
in large antral follicles and mainly induced by E2 [90] and FSH [91]. Furthermore, a
morphofunctional process determinant for follicular expansion and antrum formation is
the establishment of microtubule TZPs between germ cell and somatic cells. The TZPs
originate from a microtubule core in GC projected towards the oocyte, providing tracks for
polarized translocation of secretory pathway organelles [92]. Studies on FSHβ knockout
mice evidenced the retraction of TZPs from the oocyte, with drastic changes in oocyte
chromatin remodeling and meiotic competence acquisition. Thus, coordinated actions of
FSH and E2 on TZPs formation [93,94] ensure adequate communication between GC and
oocyte during preantral to antral follicle transition.
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Research in humans has recently revealed a number of important genes regulating
preantral to antral follicle transition [30]. Importantly, CX40 was identified as the most abun-
dant Cx in human GC of antral and preovulatory follicles. Concerning oocyte-derived fac-
tors, Activating Transcription Factor (ATF) 2 and Eomesodermin (EOMES) were abundantly ex-
pressed in the oocytes of preovulatory follicles, as well as Bone Morphogenic Protein (BMP) 15 [30].
Finally, particular relevance was given to the NOTCH pathway during preovulatory follicle
formation in women, with Delta Like Canonical Notch Ligand (DLL)3 and Jagged Canonical
Notch Ligand (JAG) 2 being predominantly expressed in the oocyte and their receptors,
NOTCH2, NOTCH3, and downstream target gene Hes Family BHLH Transcription Factor
(HES) 1, highly expressed in GC. These findings highlight the role of the NOTCH signaling
pathway regulating oocyte-mediated GC proliferation and differentiation [30].
To conclude, preovulatory follicle formation requires concerted action of gonadotropins
FSH and LH on the crosstalk between GC and TC during steroidogenesis and E2 signaling.
As a result, the formation of junctional complexes and TZPs create routes for the exchange
of metabolites and signaling molecules between somatic cells and oocyte, determining
follicle expansion and formation of the Graafian follicle.
5.2. Preovulatory Follicle Formation—The Role of Leptin
Leptin’s role in ovarian secretory activity is well established. In vitro studies with
rat GC showed leptin treatment impaired E2 secretion [95], whereas the same effect was
observed for human luteinized GC [96] or preovulatory follicles in swine [97]. Most
importantly, experiments with GC collected from fertile woman showed that treatments
with high doses of leptin had deleterious effects on FSH-mediated E2 secretion, mainly
through IGF1 inhibition [98]. These results evidenced the detrimental effects of high
leptin levels on E2 secretion by dominant follicles and consequent disruption of LH surge
and impaired ovulation. Furthermore, a recent report has shown leptin interference
with E2 secretion could be mediated by the induction of the neuropeptide cocaine- and
amphetamine-regulated transcript (CART) at GC level [99]. Leptin negatively affected
intracellular cAMP levels, MAPK signaling, and aromatase Cyp19a1 mRNA expression
with consequent downregulation of E2 synthesis [99]. Finally, we and others have also
shown leptin effects on P4 synthesis, as leptin regulated, in a dose-dependent manner,
the expression of cytochrome P450 side chain cleavage (P450 scc) and 3β hydroxysteroid
dehydrogenase (HSD) [26,27]. Therefore, obesity and consequent hyperleptinemia can
impair steroidogenesis in the growing antral follicle.
As previously stated, bidirectional communication between somatic cells and the
gamete was revealed to be essential for oocyte maturation and follicular development
progression. Interestingly, leptin was shown to modulate reorganization of actin, the main
component of projections as TZPs, in systems like the hypothalamus [100] or nucleus
pulposus cells in the intervertebral disks [101]. Recently, we have shown that pharma-
cological treatment of female mice with leptin altered the expression of genes associated
with cytoskeleton organization in CC [6]. Moreover, the role of TZPs transferring leptin
and STAT3 from GC to oocytes has been previously reported [102]. Indeed, leptin was
shown to regulate levels of Cx43 in the central nervous system (CNS) in vivo in mice [103],
reiterating its potential role mediating intercellular communication between GC and the
oocyte. On the other hand, the NOTCH pathway was shown by Zhang and co-workers
to be upregulated in human preovulatory follicle [30]. Importantly, the crosstalk between
leptin and NOTCH signaling was also shown in other systems, such as in vitro studies on
glioblastoma cells [104]. Thus, disruption in ovarian leptin signaling during obesity can
well affect steroidogenesis and the maintenance of channels for intercellular communication
during preovulatory follicle formation.
5.3. Obesity and Leptin Signaling Disruption during Preovulatory Follicle Formation
Obesity has been strongly associated with increased circulating levels of both E2 and
androgens, not only due to the ability of the adipose tissue to synthesize steroids [105]
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but also to low circulating sex hormone binding globulin levels and suppression of go-
nadotropin release. Moreover, ovarian TC are known to respond to insulin during andro-
gen synthesis [1]. Seminal work by Wu and co-workers clearly showed the link between
hyperinsulinemia in DIO mice and increased ovarian androgen production through hyper-
activation of CYP17 at TC level [106]. On the other hand, Souter et al. also correlated gain
in body mass index (BMI) with E2 secretion by preovulatory follicles in obese women [107].
Finally, studies in rats evidenced the link between obesity and the lack of preovulatory
surge of P4 and LH [108]. Hence, obesity clearly disrupts steroidogenesis, causing a
predisposition to premature follicular atresia and anovulation.
The negative impact of obesity on preovulatory follicle formation can be also related to
the expression of leptin signaling inhibitors PTP1B and SOCS3. Indeed, dephosphorylation
of human estrogen receptor by PTP1B was shown to reduce E2 binding capacity [109].
In breast cancer cells, PTP1B was also shown to reduce aromatase activity when overex-
pressed [110]. Therefore, during leptin resistance, potential increased PTP1B activity [111]
could impair aromatase activity and E2 levels in the follicle. Conversely, SOCS3 was
previously shown to block ERK1/2 signaling, an important kinase in the LH-mediated
oocyte resumption of meiosis, ovulation, and luteinization [112]. Finally, we asked to what
extent common DEGs previously identified in CCs collected from both leptin treated and
early obesity mouse protocols (4 wk HFD) could be already expressed in GC from antral
and preovulatory follicles. We used once more the data from human GC transcriptome
throughout folliculogenesis [30] and plotted the DEGs from our study in mice (134 DEGs
plus 10 leptin pathway genes—Table S2) [6]. Interestingly, most of the genes were actively
transcribed in GC from human antral and preovulatory follicles (Figure 5) as PTPN2 and
PTP1B, suggesting this way that previously observed changes in gene expression in CC
in early obesity, driven by increased leptin activity, could be seemingly important for GC
from preantral and antral follicles. To conclude, dysregulation of leptin signaling inhibitors,
through hyperactivation of ObRb and activity of downstream leptin genes, can equally
affect preovulatory follicle formation in obese mothers.
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Figure 5. Heatmap representing transcription profile of genes identified as differentially expressed
in cumulus cells of mice both fed high fat diet for 4 wk and treated with leptin (for details please
see [6]) in human granulosa cells throughout folliculogenesis. Primordial = primordial follicle;
Primary = primary follicle; Antral = antral follicle; Preovulatory = preovulatory follicle. Color code
from blue to red indicates the relative gene expression level from low to high, respectively. Data from
Zhang et al. 2018 [30]; 134 DEGs plus 10 leptin pathway genes—Table S2. Suppressor of cytokine
signaling (SOCS) 3, protein tyrosine phosphatase non-receptor type 2 (PTPN2), protein tyrosine
phosphatase (PTP) 1B.
6. Oocyte Maturation: The Last Step before Fertilization
The acquisition of developmental competence by the oocyte is a prerequisite for
fertilization and sustained embryo development. Oocyte maturation involves nuclear and
cytoplasmic transformation, which largely determine the quality of the female gamete.
Oocyte meiotic division remains blocked until hormonal signals unlock the process. The
nuclear transformation encompasses dramatic changes in chromatin organization, which
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evolves from a decondensed and transcriptionally active state in preantral follicles with a
non-surrounded nucleolus (NSN) oocyte [113] into condensed and silenced chromatin in
antral follicles with a surrounded nucleolus (SN) oocyte [113]. The cytoplasmic maturation
culminates with the reorganization of organelles and preparation for completion of meiosis.
After fertilization, meiosis is completed and maternal transcripts are degraded, with the
zygote becoming transcriptionally independent and undergoing intense cell division. In
the present section, we describe the signaling pathways leading major events orchestrating
oocyte maturation and early embryo development, particularly, highlighting potential
links to leptin signaling and its disruption during obesity.
6.1. Regulation of Oocyte Maturation
Oocyte nuclear maturation is key for meiosis accomplishment and fertilization [113].
Both human and mouse oocytes from preovulatory follicles are capable of re-entering meio-
sis; nonetheless, they remain arrested in prophase I until exiting the follicle. This allows
for the accumulation of transcripts and proteins, chromatin reorganization, and cytoplasm
maturation. Meiotic arrest was shown to be sustained by high cAMP concentrations in
the oocyte through the activity of constitutive G protein coupled receptor (GPR) 3 and/or
GPR 12 [114]. Hence, cAMP was shown to ensure high levels of PKA activity, leading to
inactivation of cell division cycle 25 homolog B (CDC25B) and maturation promoting factor
(MPF) and, therefore, enforcing meiotic arrest [115]. Receptors GPR3/12 can be activated by
multiple lysophospholipids, such as sphingosylphosphorylcholine (SPC) and sphingosine
1-phosphate (S1P), which were shown to delay spontaneous oocyte maturation [116]. More-
over, cAMP degradation by phosphodiesterase 3A (PDE3A) in the oocyte was also shown
to be prevented by exogenous cyclic guanosine monophosphate (cGMP), which appears
to be transferred from GC via gap junctions in both mice [117] and humans [118]. The
GC-derived cGMP is generated by guanylyl cyclase activity after activation of natriuretic
peptide receptors (NPR) by their ligands natriuretic peptides (NPP). The predominant
receptor in GC is NPR2 with its cognate ligand NPPC [116]. Interestingly, the expression of
the NPR2/NPPC system was shown to be regulated by E2 signaling [84]. Another recent
study showed that transforming growth factor (TGF) β upregulated the expression of
NPPC [119]. Furthermore, sex steroids were linked to meiosis resumption in a transcription
independent manner, with testosterone shown to induce oocyte maturation [120]. After
the LH surge, oocyte nuclear maturation and meiosis resumption started with germinal
vesicle (GV) breakdown (BD), morphologically characterized by the dissolution of the
oocyte nuclear envelope. Indeed, LH was shown to decrease cGMP levels through sup-
pression of NPR2 activity and inhibition of NPPC transcription in GC [116]. Finally, after
LH surge, cGMP production was stopped, Cx43 phosphorylated and gap junctions closed,
and PDE3A activated in the oocyte with rapid drop in cAMP levels [116]. As a result, MPF
could be activated and meiosis resumed.
Another pivotal step during oocyte maturation is the chromosome condensation, gen-
erally followed by meiosis progression through prometaphase I, metaphase I, anaphase I,
and extrusion of first polar body (PB) in telophase I. Finally, adequate microtubule poly-
merization is also determinant for oocyte maturation and a prerequisite for correct spindle
assembly and chromosome trafficking. The process of microtubule nucleation and sub-
sequent spindle assembly is considered chromosome-dependent in human oocytes [121].
In contrast, in mice, the spindle formation was shown to be driven by the organization of
microtubule organizing centers (MTOCs). Once the first PB is extruded, oocyte reassembles
the MII spindle with chromosomes aligned in equatorial plate, ready to extrude a second
PB upon fertilization.
Cytoplasmic oocyte maturation starts during the GVBD and comprises reorganization
of the cytoplasm, remodeling and repositioning of intracellular organelles, movement of
vesicles like Golgi and EnR, but also mitochondria repositioning around spindle [122].
Oocytes from most species, including humans, contain Balbiani bodies, which are unique
transient cytoplasmic structures for RNA storage and control of translation [123]. Addi-
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tionally, rodent oocytes contain also cytoplasmic lattices to store ribosomes. Studies with
transgenic mice showed the involvement of peptidyl arginine deiminase 6 (PADI6) [124] in
the organization of such structures, as well as the maternal effect gene maternal antigen that
embryos require (Mater) [125]. Indeed, during oocyte maturation, a tightly regulated pro-
gram of maternal mRNA synthesis, degradation, and storage, particularly mRNAs related
to ribosome and mitochondria biogenesis, is determinant for acquisition of developmental
competence and early embryo development before zygotic genome activation.
The three previously described steps for oocyte maturation (oocyte nuclear matura-
tion and meiosis resumption, chromatin condensation, and cytoplasm maturation) are
entirely dependent on oocyte metabolism. It provides energy for meiotic progression, bal-
ancing intracellular redox and osmotic potential, and provides building blocks for oocyte
growth [122]. Indeed, it was shown that oocytes collected from prepubertal cows had
reduced ability to generate viable embryos due to altered metabolic profile with regard
to adult animals [126]. Furthermore, genes controlling metabolism were shown to be
upregulated in mouse MII oocytes compared to GV oocyte [127]; also, the expression of
metabolic genes differed between in vitro and in vivo maturation in bovine oocytes [128].
Mouse oocytes mainly use pyruvate as an energy source for oxidative phosphorylation as
pyruvate can exclusively support maturation, maintain viability, and promote cleavage
of zygote in the absence of CC [129]. Glucose is mostly metabolized by CC, and together
with glucose-6-phosphate, lactate or pyruvate can be transported into the oocyte via gap
junctions. Two main oocyte- secreted factors, BMP15 and GDF9, were shown to con-
trol CC metabolism [130]. Furthermore, mitochondria significantly contribute to cellular
metabolism, and deficiencies in aerobic mitochondrial metabolism have been linked to
impaired oocyte competence [131]. Finally, lipid metabolism also plays a role in energy
production in oocyte and embryo in mice, supporting its maturation and development. In
response to LH surge, fatty acid oxidation takes place in the oocyte, with long chain fatty
acid metabolism being a source of acetyl coenzyme A (acyl-CoA), which enters tricarboxylic
cycle and electrons for nicotinamide adenine dinucleotide phosphate (NADPH) production
in the electron transport chain for adenosine triphosphate (ATP) production [132]. On
the other hand, leptin is known to promote lipid oxidation and regulation of triglyceride
cellular homeostasis [133]. Therefore, changes in leptin levels can affect oocyte fatty acid
oxidation and energy provision during oocyte maturation.
In conclusion, major steps for oocyte maturation encompass dramatic structural
changes at the nuclear and cytoplasmic level, which rely on the metabolic performance of
both oocyte and CC. Indeed, oocyte quality is known to affect embryo development, being,
therefore, the integrity of oocyte maturation and metabolic performance determinant for
early embryo development and implantation.
6.2. Leptin Effects on Oocyte Maturation
Leptin involvement in oocyte maturation and early embryo development was pre-
viously documented. Intriguingly, leptin was shown to support meiotic progression and
developmental competence of bovine oocytes, as well as fertilization and blastocyst de-
velopment [134]. Furthermore, leptin promoted nuclear and cytoplasmic maturation via
MAPK pathway activation in porcine oocytes, as in vitro studies showed increased pro-
portion of oocytes reaching MII stage, upregulation of cyclin B1 protein expression, and
enhanced embryo development [135]. In another in vitro study, the supportive effects of
leptin on GVBD formation in oocytes from preovulatory follicles were demonstrated, en-
hancing first PB extrusion and development of preimplantation embryos, mainly through
MEK1/2 signaling [136]. Reports in pancreatic beta cells revealed leptin’s ability to stimu-
late adenylate cyclase and increase cAMP cellular levels [137] and activate PDE3B [138].
Moreover, leptin treatment increased intracellular cAMP level and PKA activity in murine
macrophages [139]. Indeed, in different cellular contexts, leptin was also shown to modu-
late factors, such as cAMP and PKA activity, known to have a prominent role in meiosis
reactivation and maturation of the gamete. Finally, the role of leptin on glucose homeostasis
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systemically is well described through the modulation of the IRS/PI3K pathway [140].
Leptin was also shown to attenuate the deleterious impact of high glucose levels in oocyte,
promoting glycolysis and oocyte maturation [141]. Thus, changes in leptin signaling during
obesity can produce expected changes in oocyte metabolism.
6.3. Oocyte Maturation and Early Embryo Development in Obese Mothers
Obesity leads to severe systemic hormonal imbalance with drastic consequences for
oocyte maturation and embryo development. Firstly, maternal obesity was shown to alter
insulin, glucose, and free fatty acid concentration in follicular fluid, directly affecting oocyte
metabolism and reducing oocyte maturation [142]. Secondly, insulin-stimulated glucose
uptake was shown to be impaired in CC isolated from mice treated with HFD, suggesting
the establishment of insulin-resistance [143]. Indeed, activation of the polyol pathway
during hyperglycemia was shown to negatively affect metabolism and CC–oocyte com-
munication [144]. As a result, in obese mothers, oocyte maturation, fertilization rate, and
embryo quality were significantly decreased [145]. Moreover, oocytes derived from obese
mice after in vitro fertilization and culture presented reduced development [145]. Further-
more, studies in mice clearly linked maternal obesity with oocyte and zygote increased
mitochondrial potential, mitochondrial DNA content and biogenesis, and generation of
reactive oxygen species (ROS) [2]. Importantly, the absence of mitophagy was presented
as the main cause of mitochondrial dysfunction in oocytes and early embryos from obese
mothers [12]. Another recent report also linked lack of expression of Stella in oocytes
from obese mice with increased hydromethylation in the zygote and DNA instability [5].
Thus, obesity can drastically affect both oocyte and embryo quality. Finally, with regard to
direct effects of altered leptin signaling components in oocyte maturation, SOCS3 mRNA
was shown to be decreased in human CC collected from patients with polycystic ovary
syndrome (PCOS) [146]. Indeed, SOCS3 was suggested as a biomarker of oocyte or embryo
competence in CC of PCOS patients. In summary, maternal obesity leads to disruption in
mitochondrial dynamics, excessive free fatty acids, and cellular damage, which affect not
only the oocyte but may also hamper embryo development.
7. Conclusions
Folliculogenesis regulation is a complex process that depends on the crosstalk between
local and systemic factors, accounting, therefore, for its vulnerability to maternal physio-
logical fitness. Indeed, leptin, an established local regulator of folliculogenesis, presents
increased circulating levels in obese mothers with major consequences for follicular acti-
vation, recruitment, and growth. In addition to increased ovarian ObRb activation and
altered leptin signaling, deleterious effects of systemic hyperleptinemia during obesity can
also result from local overexpression of mediators of leptin resistance, such as SOCS3. As a
result, leptin’s prominent role as suppressor of follicular pool activation can be affected in
obese mothers, with consequent POF. During preovulatory follicle formation, altered leptin
signaling affects not only steroidogenesis but the communication between GC and oocyte,
which is known to be key for antrum formation and oocyte growth. Finally, changes in
leptin signaling and impaired metabolism may also incur drastic consequences for oocyte
maturation, hampering meiosis resumption and cytoplasmic maturation (Figure 6). Hence,
advances in our understanding of the role of leptin on ovarian pathophysiology dur-
ing obesity should unravel innovative tools to monitor the quality of the oocyte during
disease progression, potentially preventing pregnancy failure and ensuring the birth of
a healthy offspring.
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Figure 6. Adipose tissue secretes excessive amounts of leptin (L) during obesity. Leptin signaling in
the ovaries of obese mothers is altered, culminating with the establishment of leptin resistance. As a
result, signaling pathways governing primordial follicle activation, preovulatory follicle formation,
and oocyte maturation can be affected. Created with BioRender.com, accessed on 1 November 2020.
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of leptin treatment [6]. (B) The list of components of leptin signaling pathway.
Author Contributions: K.W.—original draft preparation, editing; J.C.-F.—bioinformatic data anal-
ysis, representation of transcriptome data; G.K.—review, supervision; A.G.—conceptualization,
supervision, review, editing. All authors have read and agreed to the published version of the
manuscript.
Funding: Work was supported by grants from the Polish National Science Centre (No. 2016/23/B/NZ4/03737
and 2019/34/E/NZ4/00349) awarded to A.G.; and A.G. was supported by Horizon 2020 Marie Curie
Individual Fellowship (MOBER).
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: The data presented in this study are available on request from the
corresponding author.
Conflicts of Interest: The authors declare no conflict of interest.
Int. J. Mol. Sci. 2021, 22, 4270 19 of 26
Abbreviations
acyl-CoA acetyl coenzyme A
Akt Protein kinase B
AMH Anti-Mullerian hormone
ATF Activating transcription factor
ATP Adenosine triphosphate
BDNF Brain-derived nerve factor
BMI Body mass index
BMP Bone morphogenic protein
cAMP Cyclic adenosine monophosphate
CART Cocaine- and amphetamine-regulated transcript
CC Cumulus cells
CDC25B Cell division cycle 25 homolog B
cGMP Cyclic guanosine monophosphate
CNS Central nervous system
COCs Cumulus–oocyte complexes
CREB Activates cyclic AMP-response element binding protein
Cx Connexin
CYP Cytochrome P450
DEGs Differently expressed genes
DIO Diet-induced obesity
DLL Delta like canonical notch ligand
dpc Days post coitum
E2 Estradiol
EGF Epidermal growth factor




EREs Estrogens response elements
ERK Extracellular signal regulated kinase
FGF Basic fibroblast growth factor
FIGa Folliculogenesis-specific basic helix–loop–helix




GDF Growth differentiation factor
GnRH Gonadotropin releasing hormone
GPER G protein coupled Estrogen receptor
GPR G protein coupled receptor
GVBD Germinal vesicle breakdown
HES Hes family BHLH transcription factor
HFD High-fat diet
HSD Hydroxysteroid dehydrogenase
IGF Insulin-like growth factor
IRS Insulin receptor substrate
JAG2 Jagged canonical notch ligand
JAK Janus kinase
Jaml Junction adhesion molecule like
Kit Stem cell factor receptor
LH Luteinizing hormone
Lhx8 LIM homeobox protein
MAPK Mitogen-activated protein kinase
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Mater Maternal antigen that embryos require
MEK Mitogen-activated protein kinas
MII Metaphase II oocyte
miR Micro RNA
MPF Maturation promoting factor
MTOCs Microtubule organizing centers
mTOR Mammalian target of rapamycin
mTORC1 Mammalian target of rapamycin complex 1
NADPH Nicotinamide adenine dinucleotide phosphate
NFKB Nuclear factor kappa B
NPP Natriuretic peptides
NPR Natriuretic peptide receptors
NSN Non-surrounded nucleolus oocyte
NT Neurotrophin
ObR Leptin receptor
ObRb Leptin receptor isoform b
p27 Cyclin-dependent kinase inhibitor 1B
P4 Progesterone
P450scc Cytochrome P450 side chain cleavage
PADI Peptidyl arginine deiminase
PB Polar body
PCOS Polycystic ovary syndrome
PDE3A Phosphodiesterase 3A
PDK Phosphoinositide-dependent kinase
PGC Primordial germ cells
PI3K Phosphatidylinositol 3 kinase
PIP2 Phosphatidylinositol-4,5-biphosphate
PIP3 Phosphatidylinositol-3,4,5-triphosphate
PKA Protein kinase A
PKC Protein kinase C
PLC Phospholipase C
POF Premature ovarian failure
PTEN Phosphatase and tensin homolog
PTP1B Protein tyrosine phosphatase
PTPN2 Protein tyrosine phosphatase non-receptor type 2
RNA Ribonucleic acid
ROS Reactive oxygen species
rpS6 Ribosomal protein S6
S1P Sphingosine 1-phosphate
S6K1 Ribosomal protein S6 kinase beta-1
SCF Stem cell factor
SHP-2 SH2-domain containing protein tyrosine phosphatase
SIRT Sirtuin
SN Surrounded nucleolus oocyte
SOCS3 Suppressor of cytokine signaling 3
SPC Sphingosylphosphorylcholine
STAT Signal transducer and activator of transcription
TC Theca cells
TGF Transforming growth factor
TNF Tumor necrosis factor
TSC Tuberous sclerosis complex
TZPs Transzonal projections
wk Weeks
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